BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6972768)

  • 1. Increased frequency of HLA-DR5 in scleroderma.
    Gladman DD; Keystone EC; Baron M; Lee P; Cane D; Mervert H
    Arthritis Rheum; 1981 Jun; 24(6):854-6. PubMed ID: 6972768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Association of HLA antigens with scleroderma].
    Kühnl P; Schütz K; Altmeyer P; Holzmann H; Seidl S
    Z Hautkr; 1985 Jun; 60(11):866-8. PubMed ID: 3892952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens and scleroderma.
    Ercilla MG; Arriaga F; Gratacós MR; Coll J; Lecha V; Vives J; Castillo R
    Arch Dermatol Res; 1981; 271(4):381-5. PubMed ID: 6949497
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA antigens, autoantibodies and clinical subsets in scleroderma.
    Black CM; Welsh KI; Maddison PJ; Jayson MI; Bernstein RM
    Br J Rheumatol; 1984 Nov; 23(4):267-71. PubMed ID: 6593111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histocompatibility antigens in progressive systemic sclerosis (PSS; scleroderma).
    Lynch CJ; Singh G; Whiteside TL; Rodnan GP; Medsger TA; Rabin BS
    J Clin Immunol; 1982 Oct; 2(4):314-8. PubMed ID: 6982903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.
    Kallenberg CG; Van der Voort-Beelen JM; D'Amaro J; The TH
    Clin Exp Immunol; 1981 Mar; 43(3):478-85. PubMed ID: 6945162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA antigens with anti-Scl-70-antibodies and clinical manifestations of systemic sclerosis (scleroderma).
    Hietarinta M; Ilonen J; Lassila O; Hietaharju A
    Br J Rheumatol; 1994 Apr; 33(4):323-6. PubMed ID: 8156302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies and immunogenetics in 30 patients with systemic sclerosis and their families.
    Pereira S; Black C; Welsh K; Ansell B; Jayson M; Maddison P; Rowell N
    J Rheumatol; 1987 Aug; 14(4):760-5. PubMed ID: 3499513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of progressive systemic scleroderma to several HLA-B and HLA-DR alleles.
    Luderschmidt C; Scholz S; Mehlhaff E; König G; Albert E
    Arch Dermatol; 1987 Sep; 123(9):1188-91. PubMed ID: 3498440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Takayasu's arteritis and a B-cell alloantigen in North Americans.
    Volkman DJ; Mann DL; Fauci AS
    N Engl J Med; 1982 Feb; 306(8):464-5. PubMed ID: 6977091
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of an association between diffuse systemic sclerosis and HLA-DR1 or HLA-DR5.
    Kratz LE; Boughman JA; Needleman BW
    Dis Markers; 1989; 7(4):209-13. PubMed ID: 2573446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible association between HLA-DR5 and superficial spreading melanoma (SSM).
    Mueller-Eckhardt G; Schendel DJ; Hundeiker M; Riedel T; O'Neill GJ; Riethmüller G; Mueller-Eckhardt C
    Int J Cancer; 1984 Dec; 34(6):751-5. PubMed ID: 6334654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DR5 (DR11) with systemic sclerosis (scleroderma) in Mexican patients.
    Vargas-Alarcón G; Granados J; Ibañez de Kasep G; Alcocer-Varela J; Alarcón-Segovia D
    Clin Exp Rheumatol; 1995; 13(1):11-6. PubMed ID: 7774089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biermer's anemia, Hashimoto's thyroiditis, myasthenia and malignant thymoma. HLA B8, DR3, and DR5 antigens].
    Humbert P; Dupond JL; Mallet H; Leconte des Floris R
    Presse Med; 1984 Feb; 13(7):439. PubMed ID: 6230615
    [No Abstract]   [Full Text] [Related]  

  • 17. Serologic HLA typing in cryptogenic Lennox-Gastaut syndrome.
    van Engelen BG; de Waal LP; Weemaes CM; Renier WO
    Epilepsy Res; 1994 Jan; 17(1):43-7. PubMed ID: 8174524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An HLA-DR5 homozygous cell line expresses two DS (I-A-like) molecules.
    Karr RW; Kannapell CC; Zangara RJ; Goyert SM; Silver J; Schwartz BD
    J Exp Med; 1983 Oct; 158(4):1374-9. PubMed ID: 6604786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial palindromic rheumatism: a possible association with HLA.
    Pines A; Kaplinsky N; Orgad S; Gazit E; Frankl O
    Ann Rheum Dis; 1983 Dec; 42(6):631-3. PubMed ID: 6606398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circumscribed scleroderma: internal manifestations and significant correlation to HLA-DR1 and DR5].
    Luderschmidt C; König G; Leisner B; Scholz S; Albert EE
    Hautarzt; 1985 Sep; 36(9):516-21. PubMed ID: 3877710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.